Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.6K
Overview
53.6K
Vaccine Production01:23

Vaccine Production

34
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
34
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

402
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
402
Vaccines01:21

Vaccines

41
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
41
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

2.2K
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
2.2K
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

344
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infectious disease outbreak controllability: biological, social and public health factors.

Proceedings. Biological sciences·2026
Same author

SARS-CoV-2 infection in UK university students: lessons from September-December 2020 and modelling insights for future student return.

Royal Society open science·2021
Same author

Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model.

Royal Society open science·2021
Same author

A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance.

PLoS computational biology·2019
Same author

Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities.

Science (New York, N.Y.)·2018
Same author

A new method for detecting signal regions in ordered sequences of real numbers, and application to viral genomic data.

PloS one·2018
Same journal

Effects of Seasonal Births and Predation on Disease Spread.

Bulletin of mathematical biology·2026
Same journal

Identifiability, Sensitivity, and Genetic Algorithms in Bacterial Biofilm Selection Models.

Bulletin of mathematical biology·2026
Same journal

Slow Evolution Towards Generalism in a Model of Variable Dietary Range.

Bulletin of mathematical biology·2026
Same journal

CBINN: Cancer Biology-Informed Neural Network for Unknown Parameter Estimation and Missing Physics Identification.

Bulletin of mathematical biology·2026
Same journal

A Cost-Sensitive Behavioral Modeling Analysis of the Early Identification and Control of Infectious Diseases.

Bulletin of mathematical biology·2026
Same journal

Tracking Dynamics of Superspreading Through Contacts, Exposures, and Transmissions in Edge-Based Network Epidemics.

Bulletin of mathematical biology·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper
07:38

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper

Published on: April 9, 2017

10.6K

Final-Size Solutions for SIRI Models with Vaccination.

Maria A Gutierrez1, Julia R Gog2

  • 1Odum School of Ecology, University of Georgia, Athens, USA. gutierrez@uga.edu.

Bulletin of Mathematical Biology
|March 24, 2026
PubMed
Summary
This summary is machine-generated.

This study extends the classic SIR model to account for partial immunity, allowing for reinfections. Mathematical expressions for epidemic final size are derived for both all-or-none and leaky immunity scenarios, including vaccination effects.

Keywords:
Compartmental modelsEpidemic modelFinal-size solutionPartial immunityReinfection thresholdVaccination

More Related Videos

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.4K
Quantification of Strain in a Porcine Model of Skin Expansion Using Multi-View Stereo and Isogeometric Kinematics
14:14

Quantification of Strain in a Porcine Model of Skin Expansion Using Multi-View Stereo and Isogeometric Kinematics

Published on: April 16, 2017

12.1K

Related Experiment Videos

Last Updated: Mar 27, 2026

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper
07:38

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper

Published on: April 9, 2017

10.6K
Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.4K
Quantification of Strain in a Porcine Model of Skin Expansion Using Multi-View Stereo and Isogeometric Kinematics
14:14

Quantification of Strain in a Porcine Model of Skin Expansion Using Multi-View Stereo and Isogeometric Kinematics

Published on: April 16, 2017

12.1K

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Infectious Disease Modeling

Background:

  • Classic SIR models assume complete immunity post-infection, which is unrealistic for many diseases.
  • Partial immunity and reinfection are crucial factors in understanding disease dynamics.
  • Vaccination strategies need to account for varying levels of vaccine-induced protection.

Purpose of the Study:

  • To develop mathematical models for epidemic final size with partial immunity.
  • To analyze the impact of different partial immunity interpretations (all-or-none vs. leaky) on disease transmission.
  • To incorporate vaccination into partial immunity models and assess its effects on infection dynamics.

Main Methods:

  • Mathematical modeling of infectious disease spread.
  • Derivation of analytical expressions for epidemic final size.
  • Analysis of cumulative primary and reinfections under different immunity scenarios.

Main Results:

  • Analytical expressions for epidemic final size derived for partial immunity models.
  • Distinction between all-or-none and leaky immunity impacts on cumulative infections and reinfections.
  • Identification of a reinfection threshold in the leaky immunity model, determining endemic vs. transient disease states.

Conclusions:

  • Partial immunity significantly alters epidemic dynamics compared to classic models.
  • The interpretation of partial immunity (all-or-none or leaky) has distinct consequences for disease outcomes.
  • Mathematical modeling provides crucial insights into managing infectious diseases with partial immunity and vaccination.